Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Fitzgerald

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
American Journal of Optometry and Physiological Optics|October 1, 1986
Determinants of the initial comfort of hydrogel contact lensesN Efron, N A Brennan, J M Currie, et al.
Anaesthesia|September 19, 2019
Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trialsJ P Fitzgerald, K A Fedoruk, S M Jadin, et al.
Leukemia & Lymphoma|May 24, 2011
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemiaRobert J Kreitman, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|March 1, 1974
Proceedings: The early lymphatic spread of manifest prostatic adenocarcinomaI Grossman, R von Phul, J P Fitzgerald, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|January 1, 1972
Role of radiation therapy and of surgery in the management of localized epidermoid carcinoma of the maxillary sinusS S Kurohara, J H Webster, F Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemiaRobert J Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2005
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignanciesRobert J Kreitman, David R Squires, Maryalice Stetler-Stevenson, et al.
Oncogene|August 8, 2012
Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translationB K Nayak, D Feliers, S Sudarshan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
American Journal of Optometry and Physiological Optics|October 1, 1986
Determinants of the initial comfort of hydrogel contact lensesN Efron, N A Brennan, J M Currie, et al.
Anaesthesia|September 19, 2019
Prevention of hypotension after spinal anaesthesia for caesarean section: a systematic review and network meta-analysis of randomised controlled trialsJ P Fitzgerald, K A Fedoruk, S M Jadin, et al.
Leukemia & Lymphoma|May 24, 2011
Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemiaRobert J Kreitman, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|March 1, 1974
Proceedings: The early lymphatic spread of manifest prostatic adenocarcinomaI Grossman, R von Phul, J P Fitzgerald, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|January 1, 1972
Role of radiation therapy and of surgery in the management of localized epidermoid carcinoma of the maxillary sinusS S Kurohara, J H Webster, F Ellis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2009
Phase II trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with hairy cell leukemiaRobert J Kreitman, Maryalice Stetler-Stevenson, Inger Margulies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2005
Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignanciesRobert J Kreitman, David R Squires, Maryalice Stetler-Stevenson, et al.
Oncogene|August 8, 2012
Stabilization of HIF-2α through redox regulation of mTORC2 activation and initiation of mRNA translationB K Nayak, D Feliers, S Sudarshan, et al.
Pageof 2